To explore the function of EZH2 in the development and progression of cervical carcinoma, immunohistochemistry was first conducted using paraffin-embedded normal cervix (NC), cervical carcinoma in situ (CIS), and cervical carcinoma (CC) tissues. This evidence concerns the gene EZH2 and in situ carcinoma.